SCHEMBL2146945

SCHEMBL2146945

CC1(C)[CH]CC[CH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1178649 0.60
SCHEMBL17873075 0.58
SCHEMBL321091 0.57
SCHEMBL9098607 0.55
SCHEMBL2351542 0.53
SCHEMBL16534479 0.53
SCHEMBL25338556 0.52
SCHEMBL8749598 0.52
SCHEMBL25002994 0.50
SCHEMBL1703149 0.48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2729472-B1 CARBOXYLIC ACID DERIVATIVES WITH AN OXAZOLO[4,5-C]PYRIDINE RING SANOFI SA (FR) 2016-08-24 EP disclosed
US-9321787-B2 Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring SANOFI (FR) 2016-04-26 US disclosed
EP-2729473-B1 CARBOXYLIC ACID DERIVATIVES WITH AN OXAZOLO[5,4-B]PYRIDINE RING SANOFI SA (FR) 2015-11-25 EP disclosed
EP-2729475-B1 Carboxylic acid derivatives with an oxazolo[4,5-d]pyrimidine ring SANOFI SA (FR) 2015-06-10 EP disclosed
EP-2729471-B1 CARBOXYLIC ACID DERIVATIVES WITH AN OXAZOLO[5,4-D]PYRIMIDINE RING SANOFI SA (FR) 2015-05-06 EP disclosed
US-8907093-B2 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring SANOFI (FR) 2014-12-09 US disclosed
US-8846690-B2 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring SANOFI (FR) 2014-09-30 US disclosed
US-8846692-B2 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring SANOFI (FR) 2014-09-30 US disclosed
US-8846691-B2 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring SANOFI (FR) 2014-09-30 US disclosed
US-8748436-B2 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring SANOFI (FR) 2014-06-10 US disclosed
EP-2523959-A1 HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING A 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2012-11-21 EP disclosed
EP-2523958-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2012-11-21 EP disclosed
EP-2523960-A1 HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2012-11-21 EP disclosed
WO-2011086077-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI-AVENTIS (FR) 2011-07-21 WO disclosed
WO-2011086080-A1 HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI-AVENTIS (FR) 2011-07-21 WO disclosed
WO-2011086078-A1 HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING A 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI-AVENTIS (FR) 2011-07-21 WO disclosed
US-20030199560-A1 Bisaryl compound and medicament for cancer treatment comprising the same KYOWA HAKKO KOGYO CO., LTD. 2003-10-23 US disclosed
US-6608061-B2 Antiproliferative agents KYOMA HAKKO KOGYO CO., LTD. (JP) 2003-08-19 US disclosed
US-20030018070-A1 BISARYL COMPOUND AND MEDICAMENT FOR CANCER TREATMENT COMPRISING THE SAME FUJIFILM CORPORATION (JP) 2003-01-23 US disclosed
EP-0990439-A1 BISARYL COMPOUNDS AND CANCER REMEDIES CONTAINING THE SAME KYOWA HAKKO KOGYO CO., LTD. (JP) 2000-04-05 EP disclosed